UK Markets open in 7 hrs 27 mins

Cara Therapeutics, Inc. (CARA)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
13.16-0.18 (-1.35%)
At close: 4:00PM EDT
13.20 +0.04 (+0.30%)
After hours: 07:11PM EDT
Currency in USD

Valuation measures

We're sorry, we couldn't find any data.
Please try reloading the page.

Trading information

Stock price history

Beta (5Y monthly) 1.31
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 329.65
52-week low 311.22
50-day moving average 314.95
200-day moving average 315.66

Share statistics

Avg vol (3-month) 31.53M
Avg vol (10-day) 3418.43k
Shares outstanding 550.04M
Implied shares outstanding 6N/A
Float 841.91M
% held by insiders 110.49%
% held by institutions 167.14%
Shares short (14 Apr 2021) 43.58M
Short ratio (14 Apr 2021) 42.25
Short % of float (14 Apr 2021) 47.30%
Short % of shares outstanding (14 Apr 2021) 47.16%
Shares short (prior month 14 Mar 2021) 43.21M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:2
Last split date 315 Jan 2014

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)30 Dec 2020

Profitability

Profit margin 6.23%
Operating margin (ttm)3.99%

Management effectiveness

Return on assets (ttm)1.34%
Return on equity (ttm)3.86%

Income statement

Revenue (ttm)135.08M
Revenue per share (ttm)2.85
Quarterly revenue growth (yoy)2,384.80%
Gross profit (ttm)27.23M
EBITDA 5.59M
Net income avi to common (ttm)8.41M
Diluted EPS (ttm)0.18
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)180.92M
Total cash per share (mrq)3.63
Total debt (mrq)5.28M
Total debt/equity (mrq)2.12
Current ratio (mrq)10.55
Book value per share (mrq)4.99

Cash flow statement

Operating cash flow (ttm)-5.49M
Levered free cash flow (ttm)-9.67M